Catalyst Pharmaceuticals Inc
CPRX
|
|
| |
|
| Trading Volume | 29,552 |
|
|
20.72 - 11.69 |
| Market Cap Full | $ 2.1B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 2% | -5.2% | -10.9% | 22.5% |
| Q2 | - | -3.9% | -18.9% | -15.4% |
| Q3 | - | 15.8% | -13% | 83% |
| Q4 | - | -12.7% | 42.7% | 45% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -14.3 | 11.3 | -0.6 | -5.1 | - | - | - | 15.8 | - | - | - | -5.5 |
| 2023 | |||||||||||
| -16.7 | -1.5 | 8.7 | -4 | -27.5 | 16.4 | 2.9 | 1.5 | -16.7 | 6.2 | 16.3 | 16.5 |
| 2022 | |||||||||||
| -14.9 | 35.4 | 6.3 | -8.1 | -5.5 | -2.6 | 46.1 | 31.4 | -4.6 | 8.1 | 20.9 | 10.9 |
| 2021 | |||||||||||
| 9 | 6.9 | 18.5 | -0.7 | 20.7 | 4 | 1.6 | -5.7 | -3.8 | 11.3 | 18.6 | -3.3 |
| 2020 | |||||||||||
| 14 | -2.2 | -6 | 23.1 | -9.1 | 7.2 | -6.9 | -24 | -8.6 | -0.7 | 23.2 | -8.7 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 0.3 | 0.1 | 0.1 | 0.1 |
| Q2 | 0.3 | 0.2 | 0.1 | 0.1 |
| Q3 | -0.3 | 0.2 | 0.1 | 0.4 |
| Q4 | 0 | 0.2 | 0.1 | 0.1 |
| A | 0.3 | 0.8 | 0.4 | 0.7 |